Summary of Purpose
To determine whether the administration of 1.5 million units of streptokinase intravenously within 4 hours of the onset of acute ischemic stroke would reduce morbidity and mortality at 3 months and whether outcomes may be better for those receiving therapy within 3 hours of stroke onset compared with those receiving it after 3 hours.Read More →
The following dates are available for this trial. Trial information last updated on 5 October 2000.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Randomized, double-blind, placebo-controlled trial involving 340 patients at 40 centers throughout Australia.